Trademark: 79256575
Word
D DATAVANT
Status
Registered
Status Code
700
Status Date
Tuesday, April 7, 2020
Serial Number
79256575
Registration Number
6026113
Registration Date
Tuesday, April 7, 2020
Mark Type
3000
Filing Date
Thursday, December 13, 2018
Published for Opposition
Tuesday, January 21, 2020

Trademark Owner History
Datavant, Inc. - Original Registrant
Roivant Sciences GmbH - Original Applicant

Classifications
9 Downloadable computer software for transmitting, analyzing and generating reports; downloadable Computer software for data processing in the field of healthcare, biomedical research, and clinical trial data; Downloadable computer software for providing, analyzing and generating reports in the field of healthcare, biomedical research, and clinical trial data; Downloadable computer software for data processing; Downloadable computer programs and computer operating systems for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; Downloadable computer programs and computer operating systems for the conversion, analysis, processing, storage and transmission of artificial intelligence; Downloadable artificial intelligence and machine learning software for statistical analysis, consultancy and reporting; Downloadable software for analytics in the field of public health, healthcare, pharmaceuticals, biotechnology, biomedical research and development, clinical trials as well as post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; Downloadable software for data linkage, discovery, and de-identification used in the fields of healthcare, biomedical research, and clinical trial data for the provision of medical services, public health services and healthcare services; Downloadable computer software for database integration; Downloadable computer software for creating searchable databases of information and data; Downloadable computer software featuring an electronic computer database for linking, viewing, and de-identifying healthcare and healthcare related data used in the field of healthcare, biomedical research, and clinical trial data; Downloadable computer software for accessing data and information related to healthcare services, patient medical information and clinical trial data and for controlling and managing data and information related to healthcare services, patient medical information and clinical trial data; none of the foregoing directly related to video surveillance or video based security apparatus
35 Advertising; business management; business administration; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; business data analysis and professional business consultancy services regarding statistics for biomedical research, healthcare institutions and healthcare professionals, based on artificial intelligence and machine learning; business analysis and statistical analysis of healthcare data, biomedical research and clinical trial data; systematization and compilation of data in computer databases; compilation of information into computer databases for research and analysis purposes in the fields of public health, healthcare, biomedicine, biotechnology, pharmaceuticals, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes; professional business analysis, business consultancy and statistical analysis for business purposes in the fields of public health, healthcare, pharmaceuticals, biotechnology, biomedical research and developments, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes
42 Scientific and technological services, namely, medical research and scientific research, chemical analysis in the healthcare and biomedical field; Scientific research; Chemical analysis for industrial purposes; Biomedical research services; Design and development of computer software; Cloud computing featuring software for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data; Scientific data processing analysis services; Pharmaceutical and biomedical research services, conducting clinical trials for others, post-authorization research for the marketing of medicines and commercial post-launching of medicines, epidemiological research, pharmacoepidemiological research and research evaluating epidemiological outcomes; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding analytics in the fields of public health, healthcare, pharmaceuticals, biomedical research and clinical trial data; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding information in the fields of public health, healthcare, pharmaceuticals, biomedical research and clinical trials; Providing temporary use of non-downloadable software applications accessible via a web site for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images and information; Providing temporary use of non-downloadable software applications accessible via a web site for de-identifying, linking, and analyzing data used in the field of healthcare, biomedical research, and clinical trial data regarding data in the fields of public health, healthcare, pharmaceuticals, biomedical research, patient data, clinical trials, post-authorization research for the marketing of medicines and/or commercial post-launching of medicines, epidemiological research and pharmacoepidemiological research; Providing technological online information in the fields of public health, healthcare, pharmaceuticals, patient data, biomedical research, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; Providing scientific online information online in the fields of public health, healthcare, pharmaceuticals, patient data, biomedical research, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines from a computer database or the Internet; Providing scientific research information in the field of biomedicine, clinical trials and post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; Scientific analysis in the field of scientific data relating to biomedical research and clinical trials; Research and analysis services in the scientific fields of artificial intelligence and machine learning analytics for biomedical research and healthcare institutions
The colors black and blue are claimed as a feature of the mark.
The mark consists of stylized lowercase blue "D" inside of a blue hexagon which has a break at the top right. Above the stylized lowercase blue "D" are three blue squares. Below the hexagon image is the wording "DATAVANT" in black text. The mark is displayed on a white background which is not claimed as a feature of the mark.

Trademark Events
Sep 5, 2020
Final Decision Transaction Processed By Ib
Aug 14, 2020
Final Disposition Notice Sent To Ib
Aug 14, 2020
Final Disposition Processed
Jul 7, 2020
Final Disposition Notice Created, To Be Sent To Ib
Apr 7, 2020
Registered-Principal Register
Jan 21, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 21, 2020
Published For Opposition
Jan 17, 2020
Notification Processed By Ib
Jan 1, 2020
Notification Of Possible Opposition Sent To Ib
Jan 1, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 1, 2020
Notification Of Notice Of Publication E-Mailed
Dec 17, 2019
Assigned To Lie
Dec 14, 2019
Approved For Pub - Principal Register
Dec 13, 2019
Examiner's Amendment Entered
Dec 13, 2019
Notification Of Examiners Amendment E-Mailed
Dec 13, 2019
Examiners Amendment E-Mailed
Dec 13, 2019
Examiners Amendment -Written
Dec 3, 2019
Examiner's Amendment Entered
Dec 3, 2019
Notification Of Examiners Amendment E-Mailed
Dec 3, 2019
Examiners Amendment E-Mailed
Dec 3, 2019
Examiners Amendment -Written
Nov 13, 2019
Examiner's Amendment Entered
Nov 13, 2019
Notification Of Examiners Amendment E-Mailed
Nov 13, 2019
Examiners Amendment E-Mailed
Nov 13, 2019
Examiners Amendment -Written
Oct 31, 2019
New Representative At Ib Received
Oct 16, 2019
Correction From Ib Entered - Attorney Review Required
Oct 12, 2019
Examiner's Amendment Entered
Oct 12, 2019
Notification Of Examiners Amendment E-Mailed
Oct 12, 2019
Examiners Amendment E-Mailed
Oct 12, 2019
Examiners Amendment -Written
Aug 16, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 16, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 8, 2019
New Representative At Ib Received
Jul 26, 2019
Correction Transaction Received From Ib
Jul 10, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 10, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 28, 2019
Refusal Processed By Ib
Jun 27, 2019
Change Of Owner Received From Ib
Jun 3, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Jun 3, 2019
Refusal Processed By Mpu
May 12, 2019
Non-Final Action (Ib Refusal) Prepared For Review
May 11, 2019
Non-Final Action Written
May 7, 2019
Application Filing Receipt Mailed
May 3, 2019
Assigned To Examiner
May 3, 2019
New Application Office Supplied Data Entered In Tram
May 2, 2019
Limitation From Original Application Entered
Apr 18, 2019
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24